Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.

Iwakiri Y, Groszmann RJ.

Hepatology. 2006 Feb;43(2 Suppl 1):S121-31. Review.

PMID:
16447289
2.
3.

Hemodynamic changes in splanchnic blood vessels in portal hypertension.

Colle I, Geerts AM, Van Steenkiste C, Van Vlierberghe H.

Anat Rec (Hoboken). 2008 Jun;291(6):699-713. doi: 10.1002/ar.20667. Review.

4.

Hyperdynamic state in chronic liver diseases.

Groszmann RJ.

J Hepatol. 1993;17 Suppl 2:S38-40. Review.

PMID:
8491969
5.

Mechanisms of extrahepatic vasodilation in portal hypertension.

Hennenberg M, Trebicka J, Sauerbruch T, Heller J.

Gut. 2008 Sep;57(9):1300-14. doi: 10.1136/gut.2007.144584. Epub 2008 Apr 29. Review.

PMID:
18445644
6.

Splanchnic and systemic vasodilation: the experimental models.

Wiest R.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S272-87. Review.

PMID:
17975477
7.

Splanchnic and systemic vasodilatation: the patient.

Tsai MH.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S266-71. Review. Erratum in: J Clin Gastroenterol. 2008 May-Jun;42(5):table of contents.

PMID:
17975476
8.

[Portal hypertension and angiogenesis].

Stumm M, Sieber C.

Schweiz Med Wochenschr. 2000 Feb 19;130(7):233-9. Review. German.

PMID:
10719714
9.

Pathophysiology of portal hypertension.

Gupta TK, Chen L, Groszmann RJ.

Clin Liver Dis. 1997 May;1(1):1-12. Review.

PMID:
15562664
10.

Neurohumoral fluid regulation in chronic liver disease.

Møller S, Henriksen JH.

Scand J Clin Lab Invest. 1998 Aug;58(5):361-72. Review.

PMID:
9819185
11.

[Pathogenesis of portal hypertension].

Montaño-Loza A, Meza-Junco J.

Rev Invest Clin. 2005 Jul-Aug;57(4):596-607. Review. Spanish.

PMID:
16315644
12.

Pathophysiology of portal hypertension.

Cichoz-Lach H, Celiński K, Słomka M, Kasztelan-Szczerbińska B.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:231-8. Review.

13.

Portal hypertension: from bedside to bench.

Groszmann RJ, Abraldes JG.

J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S125-30. Review.

PMID:
15758647
14.

Pathogenesis of portal hypertension.

Lebrec D, Moreau R.

Eur J Gastroenterol Hepatol. 2001 Apr;13(4):309-11. Review.

PMID:
11338055
15.

[Significance of gaseous signal molecule in the pathogenesis of cardiovascular diseases].

Jin HF, Du JB, Tang CS.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Aug;27(4):518-24. Review. Chinese.

PMID:
16178452
16.

Interaction of endothelial nitric oxide and angiotensin in the circulation.

Toda N, Ayajiki K, Okamura T.

Pharmacol Rev. 2007 Mar;59(1):54-87. Review.

17.

Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator.

Wagner CA.

J Nephrol. 2009 Mar-Apr;22(2):173-6. Review.

PMID:
19384833
18.

Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

Gatta A, Bolognesi M, Merkel C.

Mol Aspects Med. 2008 Feb-Apr;29(1-2):119-29. Epub 2007 Oct 24. Review.

PMID:
18036654
19.

Vascular deterioration in cirrhosis: the big picture.

Bosch J.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S247-53. Review.

PMID:
17975472
20.

Hemodynamic alterations in liver cirrhosis.

La Villa G, Gentilini P.

Mol Aspects Med. 2008 Feb-Apr;29(1-2):112-8. doi: 10.1016/j.mam.2007.09.010. Epub 2007 Oct 24. Review.

PMID:
18177931

Supplemental Content

Support Center